At a glance
- Originator Nonindustrial source
- Class Antibacterials
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 21 May 2001 No-Development-Reported for Bacterial infections in South Korea (Unknown route)
- 12 May 1997 New profile
- 12 May 1997 Preclinical development for Bacterial infections in South Korea (Unknown route)